recombinant vaccinia virus vaccine (Therion)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namerecombinant vaccinia virus vaccine (Therion)
Drug Alias NamerV-MUC-1 (Therion)MUVAC
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsOvarian NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTherion Biologics Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTherion Biologics Corp
Active IndicationsN/A
Inactive IndicationsOvarian NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A